Takeda to divest four diabetes products in Japan for $1.2bn
Takeda will continue to manufacture and supply the products under the sale to Teijin Pharma
ICON agrees to acquire PRA Health Sciences for $12bn
25 Feb 21PRA shareholders will own around 34% of the shares of the combined company and ICON shareholders will own…
Novartis’ Sandoz to acquire GSK’s cephalosporin antibiotics business
12 Feb 21Sandoz will obtain the global rights to GSK’s three established brands Zinnat, Zinacef and Fortum, in more than…
Horizon to acquire biotechnology firm Viela Bio for $3bn
02 Feb 21Horizon will benefit from Viela Bio’s Uplizna, and additional investigational drug candidates VIB4920, VIB7734, and VIB1116
Boston Scientific to acquire cardiac health solutions provider Preventice
22 Jan 21The acquisition of Preventice will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space
Thermo Fisher to buy molecular diagnostics firm Mesa Biotech for $450m
20 Jan 21Thermo Fisher will additionally pay up to $100m in cash, after reaching certain milestones post-closing of the transaction
Merck acquires mRNA-based contract manufacturer AmpTec
08 Jan 21The acquisition of AmpTec will allow Merck to strengthen its capabilities in developing and manufacturing mRNA, used in…
Hologic to acquire molecular diagnostics firm Biotheranostics for $230m
06 Jan 21The acquisition of Biotheranostics will allow Hologic to leverage commercial capabilities and expertise in molecular diagnostics automation
Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn
22 Dec 20The transaction includes Agios' marketed medicine Tibsovo and its oncology pipeline of Phase 3 and early-stage assets
Philips to buy medical technology firm BioTelemetry for $2.8bn
21 Dec 20The acquisition will combine Philips’ in-hospital patient monitoring capabilities with BioTelemetry’s monitoring capabilities outside the hospital